Perampanel

5 trials 2 recruiting NNeurology/Psychiatry

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

6 Countries

Phase II

Other

Phase II: 3 Other: 2

Indications tested

Epilepsy 1 Glioblastoma 1

Sponsors using this IMP

Laboratorios Cinfa S.A. 2 Eisai Limited 1 Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo 1 Universitaetsklinikum Heidelberg AöR 1

All trials

5 total

A Multicentric, Drug-Repositioning, Self Controlled Case Series (SCCS) Clinical Trial to Evaluate the Efficacy and Safety of Perampanel in I… Pending

2025-520611-14-00 Phase II 1 country Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garo…
Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge) Recruiting

2023-503938-52-00 Phase II 1 country Universitaetsklinikum Heidelberg AöR
A study to evaluate efficacy and safety of perampanel when administered together with other current antiepileptic medications in children wi… Recruiting

2023-507794-17-00 Phase II 4 countries Eisai Limited
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-504132-18-00 1 country Laboratorios Cinfa S.A.
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-503345-59-00 1 country Laboratorios Cinfa S.A.

Showing 1–5 of 5 trials

← All drugs A–Z